CAM
HURA

Cresset Asset Management’s TuHURA Biosciences HURA Stock Holding History

Cresset Asset Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Buy
+37,736
New +$46.2K ﹤0.01% 1564

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Cresset Asset Management's HURA Position: Q1 2026 in Review

Cresset Asset Management opened a new position in TuHURA Biosciences (HURA) in Q1 2026: 37,736 shares worth $67.5K. The stake represents ﹤0.01% of the portfolio and ranks #1564 among its holdings.

89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Cresset Asset Management held 37,736 shares of TuHURA Biosciences worth $67.5K as of Q1 2026.
  • TuHURA Biosciences was a new Cresset Asset Management position in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1564 holding.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.